Skip to main
HQY

HealthEquity (HQY) Stock Forecast & Price Target

HealthEquity (HQY) Analyst Ratings

Based on 11 analyst ratings
Buy
Strong Buy 27%
Buy 64%
Hold 0%
Sell 0%
Strong Sell 9%

Bulls say

HealthEquity is a leading provider of solutions that empower consumers to make informed healthcare spending decisions through their tax-advantaged accounts. With a strong and industry-leading HSA business, HQY is well positioned to benefit from the increasing popularity of high-deductible health plans and the growing adoption of HSAs. The company's recent investments in automation and AI offer potential for margin expansion, and with a strong track record of outperforming the market, we anticipate that HQY will continue to outpace its competitors and maintain its dominant market share.

Bears say

HealthEquity is positioned to continue expanding its market share through its leadership team's efforts to digitize the platform and tap into the potential for regulatory expansion, as well as its potential for inorganic growth opportunities. However, the company is facing challenges such as a potential data breach and fraud that could have significant social implications, and its valuation may not be justified due to slower growth and margins than previously assumed. It remains to be seen if the company's efforts in AI and operational efficiency will be enough to mitigate these challenges and maintain its competitiveness in the market.

HealthEquity (HQY) has been analyzed by 11 analysts, with a consensus rating of Buy. 27% of analysts recommend a Strong Buy, 64% recommend Buy, 0% suggest Holding, 0% advise Selling, and 9% predict a Strong Sell.

This aggregate rating is based on analysts' research of HealthEquity and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About HealthEquity (HQY) Forecast

Analysts have given HealthEquity (HQY) a Buy based on their latest research and market trends.

According to 11 analysts, HealthEquity (HQY) has a Buy consensus rating as of Jul 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $113.91, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $113.91, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

HealthEquity (HQY)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.